Free Trial

enVVeno Medical (NVNO) Competitors

enVVeno Medical logo
$3.41 +0.11 (+3.33%)
(As of 11/22/2024 ET)

NVNO vs. NSPR, VANI, BSGM, MBOT, IDXG, UTMD, OBIO, INFU, SGHT, and ARAY

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include InspireMD (NSPR), Vivani Medical (VANI), BioSig Technologies (BSGM), Microbot Medical (MBOT), Interpace Biosciences (IDXG), Utah Medical Products (UTMD), Orchestra BioMed (OBIO), InfuSystem (INFU), Sight Sciences (SGHT), and Accuray (ARAY). These companies are all part of the "medical" sector.

enVVeno Medical vs.

InspireMD (NYSE:NSPR) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership, community ranking and dividends.

InspireMD has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.

enVVeno Medical received 153 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 62.65% of users gave enVVeno Medical an outperform vote while only 3.90% of users gave InspireMD an outperform vote.

CompanyUnderperformOutperform
InspireMDOutperform Votes
3
3.90%
Underperform Votes
74
96.10%
enVVeno MedicalOutperform Votes
156
62.65%
Underperform Votes
93
37.35%

InspireMD has higher revenue and earnings than enVVeno Medical. InspireMD is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InspireMD$6.20M11.15-$19.92M-$0.75-3.53
enVVeno MedicalN/AN/A-$23.52M-$1.29-2.64

InspireMD currently has a consensus price target of $4.50, indicating a potential upside of 69.81%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InspireMD
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, InspireMD and InspireMD both had 2 articles in the media. InspireMD's average media sentiment score of 0.30 beat enVVeno Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InspireMD
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
enVVeno Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

44.8% of InspireMD shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 29.7% of InspireMD shares are held by company insiders. Comparatively, 17.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

enVVeno Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. enVVeno Medical's return on equity of -48.72% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
InspireMD-413.96% -69.42% -57.68%
enVVeno Medical N/A -48.72%-45.96%

Summary

InspireMD beats enVVeno Medical on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVNO vs. The Competition

MetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$59.80M$4.53B$5.38B$8.84B
Dividend YieldN/A36.79%5.13%4.09%
P/E Ratio-2.6425.65102.4617.58
Price / SalesN/A46.931,234.85158.43
Price / CashN/A53.6240.4736.33
Price / Book1.265.947.096.50
Net Income-$23.52M$13.99M$119.65M$226.22M
7 Day Performance3.96%3.27%2.06%3.76%
1 Month Performance3.02%4.64%-2.46%4.63%
1 Year Performance-13.89%47.15%33.95%29.20%

enVVeno Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVNO
enVVeno Medical
0.3771 of 5 stars
$3.41
+3.3%
N/A-13.9%$59.80MN/A-2.6419
NSPR
InspireMD
2.4472 of 5 stars
$2.58
-2.3%
$4.50
+74.4%
+10.9%$67.29M$6.20M-3.4450
VANI
Vivani Medical
3.1031 of 5 stars
$1.33
+3.1%
$3.00
+125.6%
+40.3%$78.79MN/A-2.9620
BSGM
BioSig Technologies
N/A$1.93
+3.2%
N/A-36.5%$33.06M$20,000.000.0050Positive News
MBOT
Microbot Medical
1.7327 of 5 stars
$0.92
flat
$7.00
+660.9%
-26.3%$15.58MN/A-1.1520Negative News
Gap Up
IDXG
Interpace Biosciences
N/A$2.68
flat
N/A+155.2%$11.79M$40.21M0.00152
UTMD
Utah Medical Products
3.47 of 5 stars
$64.57
+0.6%
N/A-20.8%$218.89M$50.22M15.03180Positive News
OBIO
Orchestra BioMed
2.4659 of 5 stars
$5.44
+3.0%
$15.75
+189.5%
-3.4%$206.77M$2.76M-3.3856
INFU
InfuSystem
1.6914 of 5 stars
$9.19
+1.9%
$13.00
+41.5%
N/A$195.38M$125.79M153.19499Gap Up
SGHT
Sight Sciences
2.4237 of 5 stars
$3.76
+0.8%
$5.50
+46.3%
+60.4%$190.86M$81.06M-3.69210Gap Up
ARAY
Accuray
4.7058 of 5 stars
$1.89
+2.7%
$9.00
+377.5%
-29.8%$189.57M$446.55M-10.94987Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:NVNO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners